Parallel Bio a pioneering biotech company focused on leveraging the immune system to combat diseases has introduced its latest innovation the Clinical Trial in a Dish This revolutionary
Voyager Therapeutics Inc a biotech company focused on neurogenetic medicines announced the dosing of the first participants in its Phase a single ascending dose trial of VYTAU
Ocugen Inc a biotechnology company focused on developing novel gene and cell therapies as well as vaccines has announced the completion of dosing in the second cohort of its Phase GARDian clinical trial
Arexvy the worlds first respiratory syncytial virus vaccine has recently gained approval from the Health Sciences Authority of Singapore for immunizing individuals aged years and above against lower respiratory tract disease caused by RSV This groundbreaking achievement underscores GSKs commitment
Ractigen Therapeutics a leading clinicalstage pharmaceutical company dedicated to developing innovative therapies has announced a significant achievement the approval of its Investigational New Drug
Zai Lab Limited has announced that the Center for Drug Evaluation of the China National Medical Products Administration has accepted the supplemental Biologics License Application
Protein Dynamic Solutions this week launched its StateoftheArt ProteinMentor platform technology at the PEGS Boston Summit ProteinMentor consists of a Quantum Cascade Laser
Virios Therapeutics Inc a developmentstage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases including fibromyalgia and LongCOVID
Axonics Inc today announced that it has received regulatory approval from the Therapeutic Goods Administration for marketing the Axonics F rechargefree sacral neuromodulation system in Australia to treat adults with overactive bladder Approval of the Axonics rechargefree system
Oragenics Inc a pioneering pharmaceutical company specializing in intranasal treatments for neurological disorders today announced an update on the company and its drug development program
Glenmark Pharmaceuticals Ltd has received final approval by the United States Food Drug Administration for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution Glenmarks Brimonidine Tartrate
EVQ Bio a whollyowned subsidiary of EVQ Nano today announced the successful completion of a PreInvestigational New Drug meeting with the US Food and Drug Administration
Prague, Czech Republic
Boston, MA, USA
Pennsylvania, USA
Berlin, Germany
Boston, MA, USA
BASEL, SWITZERLAND
Sydney‚ Australia
Prague, Czech Republic
Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be) University
Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be) University
Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be) University; Department of Entomology, University of California; UC Davis Comprehensive Cancer Center, University of California. Electronic address: dileep.0@gmail.com
Executive Director, Entod Pharmaceuticals
Protein Biochemist
Senior Industry Analyst, Healthcare and Life Sciences, Frost & Sullivan.
Department of Engineering Science, University of Oxford.
Associate Professor, Department of Biology, Khalifa University
Junaid Kashir is an Associate Professor in the Department of Biology at Khalifa University andhas previously chaired multiple researchadministrative committees He has been heavilyinvolved in multiple programs for training graduate clinical embryology students Dr Kashirsresearch aims to develop therapeuticdiagnostic interventions to treat infertility and understandembryologyThe drug development process is highly complex timeconsuming costly and labour intensive There are many steps involved in developing the novel therapeutics including target discovery and validation lead compound identification and optimisation preclinical studies clinical trials and finally the FDA review and approval Even after the development and approval of novel
Breast cancer prognosis is challenging due to the heterogeneity of the disease Various computational methods using bulk RNAseq data have been proposed for breast cancer prognosis However these methods suffer from limited performances or ambiguous biological relevance
AbstractAlthough there are no absolute contraindications to bariatric surgery most bariatric surgeons consider that patients with ongoing illicit drug use should not undergo such procedures The lack of clear recommendations within this field makes morbidly obese patients on opioidreplacement therapy a subgroup at risk for treatment refusal There is little
GlaxoSmithKline plc introduces BLENREP a firstinclass antiBCMA Bcell maturation antigen therapy for the treatment of adult patients with relapsed or refractory multiple myeloma who have undergone at least four prior therapies including an antiCD monoclonal antibody
SummaryHealth care reform and industry trends are driving pharmaceutical pharma companies to rethink strategy in their US pursuits The move to bundled payments accountable care comparative effectiveness research CER evidencebased medicine EBM and payments linked to performance are the direct result of regulatory and market pressures to reduc
Approximately million people worldwide are living with a rare disease and about half of those affected by rare diseases are children
Although less well known than other drug development phases human factors engineering HFE is critical to meeting regulatory expectations for drugdevic...
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Many advanced largescale AI initiatives still need to be proved successful in Pharma
Singapore has had a multidecade longterm vision for building a worldclass biomedical cluster